CYDY - CytoDyn: Leronlimab Deployed To The Frontlines Against Coronavirus
CytoDyn (CYDY) continues to expand leronlimab’s programs and has decided to take on the coronavirus “COVID-19” pandemic. Recently, the company reported that its emergency IND has been accepted and has already dosed two patients in NYC. The company has been promoting leronlimab’s ability to be the immune system’s quarterback and now has an opportunity to display its ability to help combat this deadly outbreak. If successful, I believe the healthcare and investment world will have their eyes on CytoDyn, which will hopefully lead to increased interest in leronlimab and the ticker. As a